A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
Condition: Lassa Fever Interventions: Drug: Day 1 Lower Dose (2×106 pfu); Drug: Day 1 Higher Dose (1×107 pfu); Drug: Placebo Sponsors: International AIDS Vaccine Initiative; Coalition for Epidemic Preparedness Innovations Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials